Table 4. Antimicrobial-susceptibility pattern of Gram-positive isolates to different antibiotics.
Antibiotics | Staphylococcus aureus (n=10) | Staphylococcus haemolyticus (n=6) | Staphylococcus epidermidis (n=2) |
---|---|---|---|
n (%) | n (%) | n (%) | |
Amoxicillin/clavulanic acid | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Amoxicillin | 1 (10.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Azithromycin | 10 (100.0) *** | 6 (100.0) ‡ | 2 (100.0) *** |
Cefixime | 5/5 (100.0) ‡ | 6 (100.0) ‡ | 2 (100.0) ‡ |
Cefoperazone | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Ciprofloxacin | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Clarithromycin | 10 (100.0) *** | 6 (100.0) ‡ | 2 (100.0) *** |
Clindamycin | 10 (100.0) *** | 2 (33.3) * | 2 (100.0) ‡ |
Ceftriaxone | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Cefotaxime | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Ceftizoxime | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Doxycycline | 7/7 (100.0) *** | - | 2 (100.0) *** |
Erythromycin | 10 (100.0) *** | 6 (100.0) ‡ | 2 (100.0) *** |
Cefepime | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Cefoxitin | 1/6 (17.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Nitrofurantoin | 10 (100.0) *** | 6 (100.0) ‡ | 2 (100.0) *** |
Imipenem | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Levofloxacin | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Linezolid | 10 (100.0) *** | 6 (100.0) *** | 2 (100.0) *** |
Methicillin | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Meropenem | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Oxacillin | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) *** |
Piperacillin | 1 (10.00) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Rifampicin | 10 (100.0) *** | 3 (50.0) * | 2 (100.0) *** |
Ampicillin/sulbactam | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Tigecycline | 10 (100.0) *** | 5/5 (100.0) *** | 2 (100.0) *** |
Ticarcillin | 1 (10.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Piperacillin/tazobactam | 5 (50.0) * | 6 (100.0) ‡ | 2 (100.0) ‡ |
Vancomycin | 10 (100) *** | 5 (83.3) ** | 2 (100.0) *** |
‡ Resistant
*<70% of isolates are susceptible
** 70–90% of isolates are susceptible
*** ≥ 90% of isolates are susceptible
-Intrinsic resistance